RenovoRx (RNXT) Price Target Increased by 18.52% to 8.16

The one-year average price target for RenovoRx (RNXT) was raised to $8.16/share, an 18.52% increase from the prior $6.88 target dated March 25, 2026. This is an aggregate analyst revision that signals improved analyst sentiment toward RNXT but is likely to have limited market impact absent accompanying fundamental or clinical news.

Analysis

The one-year average price target for RenovoRx (RNXT) was raised to $8.16/share, an 18.52% increase from the prior $6.88 target dated March 25, 2026. This is an aggregate analyst revision that signals improved analyst sentiment toward RNXT but is likely to have limited market impact absent accompanying fundamental or clinical news.